Philippe Denis, MD, PhD
Show Description +
The STAR-I clinical trial is reviewed and summarized by Philippe Denis, MD, PhD (France). Prof. Denis reviews the study design, initial results, safety data, and key takeaways in relation to IOP and medication reduction in the study population. Final two-year data from MINIject's STAR-I trial showed consistently positive IOP and medication reduction in patients at trial conclusion, with no safety concerns reported. Read more in the British Journal of Ophthalmology, October 2020.
Posted: 11/11/2020
Philippe Denis, MD, PhD
The STAR-I clinical trial is reviewed and summarized by Philippe Denis, MD, PhD (France). Prof. Denis reviews the study design, initial results, safety data, and key takeaways in relation to IOP and medication reduction in the study population. Final two-year data from MINIject's STAR-I trial showed consistently positive IOP and medication reduction in patients at trial conclusion, with no safety concerns reported. Read more in the British Journal of Ophthalmology, October 2020.
Posted: 11/11/2020
About iSTAR Medical
Visit us online: istarmed.com
Follow iSTAR Medical